Recent Updates
Recently added Catalysts
OGEN Positive Sentiment Score: 75/100

Oragenics, Inc. to Present at The Centurion One Capital 2nd Annual Bahamas Summit

Friday, October 18, 2024 1 min read
Key Takeaway: Oragenics, Inc. announced that it will present at the Centurion One Capital 2nd Annual Bahamas Summit, taking place from October 22-23, 2024. Michael Redmond, the President of Oragenics, will lead a corporate presentation followed by a Q&A session on October 22 at 1:20 pm ET. The company is recognized for its focus on developing nasal delivery medications aimed at treating neurological disorders and infections, including mild traumatic brain injury and Niemann Pick Disease Type C.

Market Sentiment Analysis

POSITIVE FACTORS

  • Oragenics is presenting at a notable industry summit.
  • The company focuses on innovative treatments for brain-related health conditions.
  • Engagement with investors through a Q&A session indicates transparency.

Full Press Release Details

SARASOTA, Fla., Oct. 18, 2024 (GLOBE NEWSWIRE) -- Oragenics Inc. (NYSE American: OGEN), a company focused on developing new treatments for brain-related health conditions, announced it will be presenting at the Centurion One Capital 2nd Annual Bahamas Summit to be held at the Rosewood Baha Mar Hotel on October 22-23, 2024, in Nassau, Bahamas. Michael Redmond, President of Oragenics, will participate in a corporate presentation and Q&A session on October 22, 2024 at 1:20 pm ET.
Details for the presentation are as follows:
Date: Tuesday, October 22, 2024
Presenter: Michael Redmond, President of Oragenics
Register for the event by clicking here.
Oragenics is a development-stage biotechnology company focused on nasal delivery of pharmaceutical medications in neurology and fighting infectious diseases, including drug candidates for treating mild traumatic brain injury (mTBI), also known as concussion, and for treating Niemann Pick Disease Type C (NPC), as well as proprietary powder formulation and an intranasal delivery device. For more information, please visit www.oragenics.com.

Frequently Asked Questions

When is Oragenics' presentation at the Bahamas Summit?

Oragenics will present on October 22, 2024, at 1:20 pm ET.

Who will represent Oragenics at the event?

Michael Redmond, the President of Oragenics, will present.

What is Oragenics' primary focus?

The company focuses on developing treatments for brain health conditions.

Where is the Bahamas Summit taking place?

The event will be held at the Rosewood Baha Mar Hotel in Nassau, Bahamas.

What conditions does Oragenics aim to treat?

They aim to treat mild traumatic brain injury and Niemann Pick Disease Type C.

Tags: OGEN Viatris Investor Conferences Healthcare Oragenics Bahamas Summit mild traumatic brain injury Niemann Pick Disease biotechnology
Last updated: Oct 18, 2024